GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer ..... Also in 2013 GSK joined AllTrials, a British campaign to ensure that all ...


Jan 19, 2018 ... In Wyeth v. Levine, the Supreme Court held that claims against a manufacturer of a brand-name prescription drug for failure to warn adequately ...


Jan 5, 2009 ... Pfizer, Inc., 01/05/2009, 08-1491 - US 8th Circuit | FindLaw. ... Jr., and Nolan E. Awbrew, Birmingham, AL, James A. Simpson, Jr., Searcy, AR, ...


County, Arkansas v. Pfizer, Inc., 2009. WL 17992 (8th Cir. Jan. 5, 2009). ... tion of similar lawsuits against all types of commercial enterprises. Id. at *9. The Eighth ...


Aug 2, 2017 ... Company (P&G) do not oppose centralization in the District of New Jersey. Various Takeda ... In support of this new motion, plaintiffs, AstraZeneca, and Pfizer argue that the number of. 4 involved .... LEAR v. ASTRAZENECA PHARMACEUTICALS LP, ET AL., C.A. No. 3:17-00240 ..... KETCHUM, ET AL. v.


Mar 15, 2017 ... Drs. Ketchum, Soni, Braeckman, and Juliano, and Mr. Doyle, are current or ... Ionis, Matinas BioPharma Inc, Merck, Novartis, Pfizer, Regeneron, and Sanofi‐ Synthelabo. ... Funding information The trial is sponsored by Amarin Pharma Inc. ... Ginsberg HN, Elam MB, Lovato LC, et al; ACCORD Study Group .


Nov 26, 2013 ... C vs A: 0.737 (0.674–0.806). AUCINF .... All other authors are employees of BMS or Pfizer Inc. ... Granger CB, Alexander JH, McMurray JJ, et al.


May 15, 2013 ... The modified ITT (MITT) population comprised all ITT patients with a confirmed ... 4 μg/ml (susceptible dose-dependent), and > 4 μg/ml (resistant) based on Pfaller et al. ..... Anidulafungin versus fluconazole for invasive candidiasis. ... Pfizer Inc. Eraxis™ (anidulafungin) US physician prescribing information.


Aug 25, 2009 ... Jonathan D. Ketcham ... Medication recommendation (any medication vs none, on-patent ... cannot account for all factors that may influence patient treatment. ... from Wolters Kluwer Health, a pharmaceutical market research company. ..... Survey costs and the authors' time were funded by Pfizer Inc. The ...